ITRM vs LDOS · rev $390.0K vs P/E 16, rev $16.66B
Iterum Therapeutics PLC (ITRM) versus Leidos Holdings Inc (LDOS) — a side-by-side from cached financials, not a winner call.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
Leidos Holdings Inc (LDOS) is a information technology services company listed on US.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
Latest reported LDOS revenue for 2025-01-03 was $16.66B. Net income was $1.25B. Revenue was up 7.9% from 2023-12-29 to 2025-01-03. LDOS currently screens at market cap $20.04B and trailing P/E 15.7.
ITRM currently screens at market cap $38.6M. LDOS currently screens at market cap $20.04B and trailing P/E 15.7.
Not investment advice. Open the ITRM and LDOS stock pages for the full models.
Not investment advice.